Myeloid sarcoma: presentation, diagnosis, and treatment

LM Almond, M Charalampakis, SJ Ford… - … Myeloma and Leukemia, 2017 - Elsevier
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare
condition, most often associated with acute myeloid leukemia (AML), although in some rare …

T cell acute lymphoblastic leukemia (T-ALL): new insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies

E Vadillo, E Dorantes-Acosta, R Pelayo, M Schnoor - Blood reviews, 2018 - Elsevier
T-cell acute lymphoblastic leukemia (T-ALL) accounts for 15% and 25% of total childhood
and adult ALL cases, respectively. During T-ALL, patients are at risk of organ infiltration by …

[HTML][HTML] Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M Heuser, Y Ofran, N Boissel, SB Mauri… - Annals of …, 2020 - annalsofoncology.org
Acute myeloid leukaemia (AML) incidence is age dependent, rising markedly in patients
aged! 60 years. Ageing of the European population may therefore contribute to the reported …

[HTML][HTML] Granulocytic sarcoma: a systematic review

AF Yilmaz, G Saydam, F Sahin… - American journal of blood …, 2013 - ncbi.nlm.nih.gov
Granulocytic sarcoma also called myeloid sarcoma is an extramedullary tumor of immature
granulocytic cells. It is a rare entity, and mostly accompanied by acute myeloid leukemia. It is …

Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology

DA Arber, MJ Borowitz, M Cessna… - … of pathology & …, 2017 - meridian.allenpress.com
Context.—A complete diagnosis of acute leukemia requires knowledge of clinical
information combined with morphologic evaluation, immunophenotyping and karyotype …

Myeloid sarcoma

M Magdy, N Abdel Karim, I Eldessouki… - Oncology Research …, 2019 - karger.com
Hematological malignancies can manifest as extramedullary soft tissue masses in relatively
rare cases. The rarity of it causes a diagnostic and therapeutic challenge. One of the rarest …

[HTML][HTML] Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

JN Eckardt, F Stölzel, D Kunadt, C Röllig… - Journal of Hematology & …, 2022 - Springer
Background Extramedullary manifestations (EM) are rare in acute myeloid leukemia (AML)
and their impact on clinical outcomes is controversially discussed. Methods We …

[HTML][HTML] Hematopoietic cell transplantation in the treatment of pediatric acute myelogenous leukemia and myelodysplastic syndromes: guidelines from the American …

K Tarlock, ML Sulis, JH Chewning, JA Pollard… - … and Cellular Therapy, 2022 - Elsevier
The role of allogeneic hematopoietic stem cell transplantation (HCT) in the treatment of
acute myelogenous leukemia (AML) in children is reviewed and critically evaluated in this …

Leukemia cutis–epidemiology, clinical presentation, and differential diagnoses

G Wagner, K Fenchel, W Back, A Schulz… - JDDG: Journal der …, 2012 - Wiley Online Library
Leukemia cutis is an extramedullary manifestation of leukemia. The frequency and age
distribution depend on the leukemia subtype. The clinical and morphological findings have a …

[HTML][HTML] Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

G Goyal, AC Bartley, MM Patnaik, MR Litzow… - Blood cancer …, 2017 - nature.com
Extramedullary myeloid sarcoma (MS, also known as granulocytic sarcoma, myeloblastoma
or chloroma) is a rare form (o1%) of extramedullary acute myeloid leukemia (AML) …